Clik here to view.
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final...
View ArticleClik here to view.
Curi RMB Capital Opposes Taisho Pharmaceutical HD’s Management Buyout
CHICAGO Curi RMB Capital opposes the management buyout (“the MBO”) of Taisho Pharmaceutical Holdings Co., Ltd. (4581 JP, TSE Standard, “Taisho”) because we believe the MBO is unfair and ignores the...
View ArticleClik here to view.
キュリRMB：大正製薬HDのMBOに反対します
シカゴ （ビジネスワイヤ） — キュリRMBキャピタル（以下「キュリRMB」といいます。）は、大正製薬ホールディングス株式会社（コード番号4581、東証スタンダード、以下「大正製薬」といいます。）において実施されているマネジメント・バイアウト（以下「本件MBO」といいます。）は、一般株主の利益を無視した不公正なものであると考え、臨時株主総会において関連議案に反対する予定です。...
View ArticleClik here to view.
Sinovac Amends Shareholder Rights Plan
BEIJING Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its...
View ArticleClik here to view.
MMI Raises $110 Million in Series C Financing
JACKSONVILLE, Fla. MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today...
View ArticleClik here to view.
MMI、シリーズC資金調達で1億1000万ドルを調達
フロリダ州ジャクソンビル （ビジネスワイヤ） — 複雑な病状を抱える患者の治療選択肢を増やし、臨床転帰の改善に取り組むロボット企業のMMI (Medical Microinstruments,...
View ArticleClik here to view.
MMI在 C 轮融资中筹资1.1亿美元
杰克逊维尔，佛罗里达州 (美国商业资讯)– MMI（Medical Microinstruments, Inc.），一家专注于通过机器人技术增加治疗方案并改善复杂病症患者的临床结果的公司，今日宣布成功完成1.1亿美元的C轮融资。该轮融资由富达管理研究公司（Fidelity Management & Research...
View ArticleClik here to view.
Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic...
CAMBRIDGE, Mass. & SINGAPORE Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disorders and...
View ArticleClik here to view.
Clinical Review of Pegylated Interferons Suggests Formulation and Mechanism...
BURLINGTON, Mass. PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven...
View ArticleClik here to view.
Parse Biosciences推出Evercode全转录组第3版，提升易用性和性能
西雅图 (美国商业资讯)– Parse Biosciences，作为单细胞测序解决方案的领先提供商，今日宣布其旗舰产品Evercode™全转录组产品线的重大更新。Evercode全转录组第3版套件将于三月中旬开始提供，为研究者们带来更加高效的工作流程、更加灵活及高通量的样本处理能力，以及经过优化的试剂，显著提升了基因检测的灵敏度。...
View ArticleClik here to view.
Caldera Medical’s Humanitarian Effort Reaches New Heights: 400,000 Women...
LOS ANGELES Caldera Medical, renowned for its dedication to improving the quality of life for women, has announced significant milestones in its global humanitarian program. In partnership with...
View ArticleClik here to view.
Accresa and Intellect Partner to Offer Mental Wellbeing Support to America’s...
DALLAS Intellect and Accresa are providing employees throughout the United States with greater access to modern mental wellbeing support. The newly formed partnership highlights Intellect’s...
View ArticleClik here to view.
パース・バイオサイエンシズがEvercode Whole Transcriptomeバージョン3を発表、使いやすさと性能を大幅に改善
SEATTLE （ビジネスワイヤ） — アクセスが容易でスケーラブルなシングルセル・シーケンシング・ソリューションのリーディング・プロバイダーのパース・バイオサイエンシズは、このほど当社の主力製品であるEvercode™ Whole Transcriptomeの機能を大幅に拡大した新バージョンを発表しました。3月中旬に出荷が予定されているEvercode Whole...
View ArticleClik here to view.
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of...
SAN DIEGO Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Eisai Co., Ltd. obtained marketing authorization approval in January 2024 from the Japanese Ministry of...
View ArticleClik here to view.
MHRA Issues Notice of Acceptance for POLARIS-AD, a Phase 3 Early Alzheimer’s...
SEONGNAM-SI, South Korea AriBio Co., Ltd. (AriBio) receives Notice of Acceptance for POLARIS-AD, a Phase 3 early Alzheimer’s disease clinical trial from the Medicines and Healthcare Products...
View ArticleClik here to view.
Radisys推出Engage Clarity，改善听力损失人士的电话交流体验
俄勒冈州希尔斯伯勒 (美国商业资讯)– 世界卫生组织估计，目前全球20%的人口患有某种程度的听力损失。到2050年，这一数字预计将增加到约25%（近 25 亿）。听力损失者往往会渐渐停止社交活动，从而影响到亲友，并增加其他疾病风险，包括罹患痴呆症的可能性升高。听力问题导致电话交谈的难度尤其明显，这是因为电话不是针对听力损失人士设计，并且缺乏诸如唇读之类可以帮助克服某些听力困难的视觉提示。...
View ArticleClik here to view.
MHRA签发AriBio Co., Ltd赞助的早期阿尔茨海默病第三期临床试验POLARIS-AD的受理通知
韩国城南市 (美国商业资讯)– AriBio Co., Ltd.（AriBio）收到英国药品和保健品监管局 （MHRA）签发的早期阿尔茨海默病第三期临床试验POLARIS-AD的受理通知。MHRA于2月21日完成审查并确认了有利的道德意见，公司预计于2024年第一季度末之前在英国启动该临床试验。...
View ArticleClik here to view.
Clik here to view.
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s...
BOSTON PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases,...
View ArticleClik here to view.
Caldera Medical的人道主义援助再创新高：已为全球40万名女性提供治疗
洛杉矶 (美国商业资讯)– 以提高女性生活质量为己任的Caldera Medical宣布了其全球人道主义计划中的重要里程碑。通过与全球外科医生合作，该计划彻底改变了女性的医疗保健状况，尤其是在医疗服务不足的地区。 自2016年该计划扩展以来，Caldera...
View Article